Clinical Trial Update: rFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on prophylactic use of recombinant activated factor VII (rFVIIa) in children with Hemophilia A with inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia with Inhibitors

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Hemophilia A With Inhibitors | Phase 2 | Status: UNKNOWN